APOTEX TECHNOLOGIES INC.
Patent Owner
Stats
- 11 US PATENTS IN FORCE
- 4 US APPLICATIONS PENDING
- Aug 31, 2017 most recent publication
Details
- 11 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 175 Total Citation Count
- Feb 21, 1997 Earliest Filing
- 27 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0056,341 Extended Release Dosage Form Comprising Cyclobenzaprine HydrochlorideFeb 22, 16Mar 02, 17[A61J, A61K]
2017/0056,342 Extended Release Dosage Form Comprising Cyclobenzaprine HydrochlorideAug 31, 15Mar 02, 17[A61J, A61K]
2017/0056,343 Extended Release Dosage Form Comprising Cyclobenzaprine HydrochlorideJul 14, 16Mar 02, 17[A61K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8735602 Pharmaceutically acceptable salts of thymodepressin and processes for their manufactureMar 19, 12May 27, 14[C07D]
8207217 Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophanFeb 11, 08Jun 26, 12[A61K, C07D]
8138221 Pharmaceutically acceptable salts of thymodepressin and processes for their manufactureDec 13, 07Mar 20, 12[A61K, C07D]
8119606 Crystalline D-isoglutamyl-D-tryptophan and the mono ammonium salt of D-isoglutamyl-D-tryptophanNov 26, 07Feb 21, 12[A61K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2015/0225,341 PHARMACEUTICALLY ACCEPTABLE SALTS OF THYMODEPRESSIN AND PROCESSES FOR THEIR MANUFACTUREAbandonedFeb 10, 14Aug 13, 15[C07D]
2015/0011,484 PRODRUGS OF D-GAMMA-GLUTAMYL-D-TRYPTOPHAN AND D-GAMMA-GLUTAMYL-L-TRYPTOPHANAbandonedMar 30, 12Jan 08, 15[C07K]
8664262 Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophanExpiredJun 07, 12Mar 04, 14[A61K, C07D]
8592607 Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophanExpiredJun 07, 12Nov 26, 13[C07D]
8507449 Crystalline D-isoglutamyl-D-tryptophan and the mono ammonium salt of D-isoglutamyl-D-tryptophanExpiredFeb 20, 12Aug 13, 13[A61K, C07K]
8481588 Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophanExpiredJun 07, 12Jul 09, 13[A61K, C07D]
8476235 Crystalline D-isoglutamyl-D-tryptophan and the mono ammonium salt of D-isoglutamyl-D-tryptophanExpiredFeb 20, 12Jul 02, 13[A61K]
2013/0023,569 Use of Deferiprone for Treatment and Prevention of Iron-Related Eye DisordersAbandonedNov 12, 09Jan 24, 13[A61K, A61P]
2012/0157,387 ORALLY BIOAVAILABLE D-GAMMA-GLUTAMYL-D-TRYPTOPHANAbandonedFeb 20, 12Jun 21, 12[A61K, A61P, C07K]
2011/0240,504 METHOD AND APPARATUS FOR PACKAGING AND DISPENSING PHARMACEUTICALSAbandonedDec 03, 09Oct 06, 11[A61K, B65D, B65B]
2006/0183,890 Isopropanolate of azithromycin and method of manufacturingAbandonedMar 19, 04Aug 17, 06[A61K, C07H]
RE39087 Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereofExpiredJun 05, 03May 02, 06[A61K]
6476229 Processes for the manufacturing of 3-hydroxy-N,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamideExpiredMar 19, 02Nov 05, 02[C07D]
6472532 Processes for the manufacturing of 3-hydroxy-n,1,6-trialkyl-4-OXO-1,4-dihydropyridine-2-carboxamideExpiredMar 19, 02Oct 29, 02[C07D]
6468977 Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymesExpiredMay 23, 00Oct 22, 02[A61K, C07D]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.